Skip to main content

Chronic Liver Disease - Hepatitis A Vaccination

CBE ID
0635
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
1.6 Measure Description

The percentage of adult patients with chronic liver disease who have received a hepatitis A vaccine

    Measure Specs
      General Information
      1.7 Measure Type
      1.3 Electronic Clinical Quality Measure (eCQM)
      1.8 Level of Analysis
      1.9 Care Setting
      1.20 Types of Data Sources
      1.14 Numerator

      Patients with chronic liver disease who have received a hepatitis A vaccine.

      1.15 Denominator

      All patients, ages 18 and older, diagnosed with chronic liver disease

      Exclusions

      Specific Exclusions: 1. Patients with a previous history of viral hepatitis 2. Patients who report an allergy to Hepatitis A vaccine A. General exclusions: 1. Evidence of metastatic disease or active treatment of malignancy (chemotherapy or radiation therapy) in the last 6 months; 2. Patients who have been in a skilled nursing facility in the last 3 months (this exclusion is included to avoid holding physicians who care for patients during a transitional period, e.g. temporary SNF placement, for their ongoing care; hence, the time limitation of 3 months).

      Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed GI and GU Endorsement Maintenance Project
      Initial Endorsement
      Last Updated
      Removal Date
      Steward Organization
      ActiveHealth Management
      Steward POC email
      bvir@activehealth.net
      Steward Organization Copyright

      This information, including any attachments hereto, is the sole, exclusive, proprietary and confidential property of ActiveHealth Management, Inc., and is for the exclusive use of The National Quality Forum. Any use, copying, disclosure, dissemination or distribution by anyone other than the National Quality Forum is strictly prohibited.

                Public Comments